Vote Scores

Home / Companies / T2 Biosystems, Inc. / 15 Sep 2023

Meeting · year to 30 June 202437 filers reporting

T2 Biosystems, Inc.: meeting of 15 Sep 2023

Votes reported on Form N-PX, item by item

37 Form N-PX filers reported votes at the T2 Biosystems, Inc. meeting of 15 Sep 2023. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 60.0% of reported votes for; one filer withheld from or voted against at least one nominee.

13 vote records from 3 filers. 0 of the 2 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

33.3% for0.0% against66.7% other0.0% against management3 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

40 vote records from 35 filers. 0 of the 33 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

94.3% for0.0% against5.7% other0.0% against management35 filers100.0% for0.0% against0.0% against management373,126 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

6 vote records from 3 filers. 0 of the 2 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

66.7% for0.0% against33.3% other0.0% against management3 filers100.0% for0.0% against0.0% against management2,819 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

11 vote records from 3 filers. 0 of the 2 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

66.7% for0.0% against33.3% other0.0% against management3 filers100.0% for0.0% against0.0% against management5,638 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

15 vote records from 5 filers. 2 of the 4 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

40.0% for40.0% against20.0% other50.0% against management5 filers37.3% for62.7% against62.7% against management8,986 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

7 vote records from 3 filers. 1 of the 2 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

33.3% for33.3% against33.3% other50.0% against management3 filers53.1% for46.9% against46.9% against management2,819 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
BlackRock and iSharesForForFor
FidelitySplit or no voteForFor
State Street and SPDRNo reportForNo report
John Hancock and ManulifeNo reportForNo report
Goldman SachsNo reportForNo report
BNY MellonNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the T2 Biosystems, Inc. meeting?

37 Form N-PX filers reported votes at the meeting of 15 Sep 2023. On say-on-pay, 0 of 33 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by T2 Biosystems, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for T2 Biosystems, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing T2 Biosystems, Inc. with a meeting date within three days of 15 Sep 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.